Trials / Completed
CompletedNCT03826030
Transcranial Direct Current Stimulation for Post-stroke Motor Recovery
TRANScranial Direct Current Stimulation for POst-stroke Motor Recovery - a Phase II sTudy (TRANSPORT 2)
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 129 (actual)
- Sponsor
- Duke University · Academic / Other
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
This research study is to find out if brain stimulation at different dosage level combined with an efficacy-proven rehabilitation therapy can improve arm function. The stimulation technique is called transcranial direct current stimulation (tDCS). The treatment uses direct currents to stimulate specific parts of the brain affected by stroke. The adjunctive rehabilitation therapy is called "modified Constraint-Induced Movement Therapy" (mCIMT). During this therapy the subject will wear a mitt on the hand of the arm that was not affected by a stroke and force to use the weak arm. The study will test 3 different doses of brain stimulation in combination with mCIMT to find out the most promising one.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Sham | Sham group only receives 30 seconds of stimulation at 2mA in the beginning to create a sensory perception to the scalp in order to blind the subject. |
| DEVICE | Low dose tDCS | The low dose tDCS group receives direct current stimulation at 2 mA for 30 minutes per session |
| DEVICE | High dose tDCS | The high dose tDCS group receives direct current stimulation at 4 mA for 30 minutes per session |
| BEHAVIORAL | mCIMT | All three tDCS groups receive constraint-induced movement therapy as the adjunctive behavioral therapy for 2 hours per session |
Timeline
- Start date
- 2019-09-01
- Primary completion
- 2024-09-19
- Completion
- 2024-09-19
- First posted
- 2019-02-01
- Last updated
- 2025-08-22
- Results posted
- 2025-08-22
Locations
14 sites across 1 country: United States
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT03826030. Inclusion in this directory is not an endorsement.